EU5 Needle Free Injections Market Outlook to 2023

EU5 Needle Free Injections Market Outlook to 2023


  • Products Id :- GDMECR0673DB
  • |
  • Pages: 70
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

EU5 Needle Free Injections Market Outlook to 2023

Summary

GlobalData's new report, "EU5 Needle Free Injections Market Outlook to 2023", provides key market data on the EU5 Needle Free Injections market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Needle Free Injections.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Needle Free Injections.

Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market segments.

Global corporate-level profiles of key companies operating within the EU5 Needle Free Injections market.

Key players covered include INJEX-Equidyne Systems, Bioject Medical Technologies Inc and Antares Pharma Inc.

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 What Is This Report About? 6

2.2 Needle Free Injections Market Segmentation 6

2.3 Definitions of Markets Covered in the Report 6

3 Needle Free Injections Market, EU5 7

3.1 Needle Free Injections Market, EU5, Revenue ($m), 2009-2023 7

3.2 Needle Free Injections Market, EU5, Revenue ($m), 2009-2016 9

3.3 Needle Free Injections Market, EU5, Revenue ($m), 2016-2023 10

3.4 Needle Free Injections Market, EU5, Volume (Units), 2009-2023 11

3.5 Needle Free Injections Market, EU5, Volume (Units), 2009-2016 13

3.6 Needle Free Injections Market, EU5, Volume (Units), 2016-2023 14

3.7 Needle Free Injections Market, EU5, Company Share by Revenue ($m), 2016 15

4 Needle Free Injections Market, France 17

4.1 Needle Free Injections Market, France, Revenue ($m), 2009-2016 17

4.2 Needle Free Injections Market, France, Revenue ($m), 2016-2023 18

4.3 Needle Free Injections Market, France, Volume (Units), 2009-2016 19

4.4 Needle Free Injections Market, France, Volume (Units), 2016-2023 20

4.5 Needle Free Injections Market, France, Average Price ($), 2009-2023 21

4.6 Needle Free Injections Market, France, Distribution Share by Revenue ($m), 2015-2016 22

4.7 Needle Free Injections Market, France, Company Share by Revenue ($m), 2016 23

5 Needle Free Injections Market, Germany 25

5.1 Needle Free Injections Market, Germany, Revenue ($m), 2009-2016 25

5.2 Needle Free Injections Market, Germany, Revenue ($m), 2016-2023 26

5.3 Needle Free Injections Market, Germany, Volume (Units), 2009-2016 27

5.4 Needle Free Injections Market, Germany, Volume (Units), 2016-2023 28

5.5 Needle Free Injections Market, Germany, Average Price ($), 2009-2023 29

5.6 Needle Free Injections Market, Germany, Distribution Share by Revenue ($m), 2015-2016 30

5.7 Needle Free Injections Market, Germany, Company Share by Revenue ($m), 2016 31

6 Needle Free Injections Market, Italy 33

6.1 Needle Free Injections Market, Italy, Revenue ($m), 2009-2016 33

6.2 Needle Free Injections Market, Italy, Revenue ($m), 2016-2023 34

6.3 Needle Free Injections Market, Italy, Volume (Units), 2009-2016 35

6.4 Needle Free Injections Market, Italy, Volume (Units), 2016-2023 36

6.5 Needle Free Injections Market, Italy, Average Price ($), 2009-2023 37

6.6 Needle Free Injections Market, Italy, Distribution Share by Revenue ($m), 2015-2016 38

6.7 Needle Free Injections Market, Italy, Company Share by Revenue ($m), 2016 39

7 Needle Free Injections Market, Spain 41

7.1 Needle Free Injections Market, Spain, Revenue ($m), 2009-2016 41

7.2 Needle Free Injections Market, Spain, Revenue ($m), 2016-2023 42

7.3 Needle Free Injections Market, Spain, Volume (Units), 2009-2016 43

7.4 Needle Free Injections Market, Spain, Volume (Units), 2016-2023 44

7.5 Needle Free Injections Market, Spain, Average Price ($), 2009-2023 45

7.6 Needle Free Injections Market, Spain, Distribution Share by Revenue ($m), 2015-2016 46

7.7 Needle Free Injections Market, Spain, Company Share by Revenue ($m), 2016 47

8 Needle Free Injections Market, United Kingdom 49

8.1 Needle Free Injections Market, United Kingdom, Revenue ($m), 2009-2016 49

8.2 Needle Free Injections Market, United Kingdom, Revenue ($m), 2016-2023 50

8.3 Needle Free Injections Market, United Kingdom, Volume (Units), 2009-2016 51

8.4 Needle Free Injections Market, United Kingdom, Volume (Units), 2016-2023 52

8.5 Needle Free Injections Market, United Kingdom, Average Price ($), 2009-2023 53

8.6 Needle Free Injections Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 54

8.7 Needle Free Injections Market, United Kingdom, Company Share by Revenue ($m), 2016 55

9 Overview of Key Companies in EU5 Needle Free Injections Market 57

9.1 INJEX-Equidyne Systems 57

9.1.1 Company Overview 57

9.2 Bioject Medical Technologies Inc 57

9.2.1 Company Overview 57

9.3 Antares Pharma Inc 57

9.3.1 Company Overview 57

9.4 PharmaJet Inc 57

9.4.1 Company Overview 57

10 Needle Free Injections Market Pipeline Products 58

11 Recent Developments 59

11.1 Corporate Communications 59

11.1.1 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 59

11.1.2 Feb 22, 2017: Change in the B. Braun Management Board 59

11.1.3 Dec 14, 2016: Consort Medical: Directorate Change 59

11.1.4 Nov 25, 2016: Consort Medical: CFO Appointment 59

11.1.5 Nov 14, 2016: Olympus VISERA 4K UHD Receives "Excellence in Surgical Products Awards," Minimally Invasive Surgical Product Category 60

11.1.6 Aug 17, 2016: Consort Medical Announces Directorate Change 61

11.2 Financial Announcements 61

11.2.1 Jun 15, 2017: Consort Medical: Full year results 61

11.2.2 Mar 31, 2017: B. Braun continues its sales and earnings growth 62

11.2.3 Dec 06, 2016: Consort Medical Reports Interim Results Results For The Six Months Ended 31 October 2016 63

11.3 Other Significant Developments 64

11.3.1 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 64

12 Appendix 66

12.1 Research Methodology 67

12.1.1 Coverage 67

12.1.2 Secondary Research 67

12.1.3 Primary Research 68

12.1.4 Company Share Analysis 68

12.1.5 Distribution Share Analysis 68

12.1.6 Benchmarking 69

12.2 GlobalData Consulting 69

12.3 Contact Us 70

12.4 Disclaimer 70

1.2 List of Figures

Figure 1: Needle Free Injections Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2009-2023 7

Figure 2: Needle Free Injections Market, EU5, Revenue ($m), Historic, USD Constant, 2009-2016 9

Figure 3: Needle Free Injections Market, EU5, Revenue ($m), Forecast, USD Constant, 2016-2023 10

Figure 4: Needle Free Injections Market, EU5, Volume (Units), 2009-2023 11

Figure 5: Needle Free Injections Market, EU5, Volume (Units), Historic, 2009-2016 13

Figure 6: Needle Free Injections Market, EU5, Volume (Units), Forecast, 2016-2023 14

Figure 7: Needle Free Injections Market, EU5, Company Share (%) 2016 15

Figure 8: Needle Free Injections Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 17

Figure 9: Needle Free Injections Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 18

Figure 10: Needle Free Injections Market, France, Volume (Units), Historic, 2009-2016 19

Figure 11: Needle Free Injections Market, France, Volume (Units), Forecast, 2016-2023 20

Figure 12: Needle Free Injections Market, France, Company Share (%) 2016 23

Figure 13: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 25

Figure 14: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 26

Figure 15: Needle Free Injections Market, Germany, Volume (Units), Historic, 2009-2016 27

Figure 16: Needle Free Injections Market, Germany, Volume (Units), Forecast, 2016-2023 28

Figure 17: Needle Free Injections Market, Germany, Company Share (%) 2016 31

Figure 18: Needle Free Injections Market, Italy, Revenue ($m), USD Constant, Historic, 2009-2016 33

Figure 19: Needle Free Injections Market, Italy, Revenue ($m), USD Constant, Forecast, 2016-2023 34

Figure 20: Needle Free Injections Market, Italy, Volume (Units), Historic, 2009-2016 35

Figure 21: Needle Free Injections Market, Italy, Volume (Units), Forecast, 2016-2023 36

Figure 22: Needle Free Injections Market, Italy, Company Share (%) 2016 39

Figure 23: Needle Free Injections Market, Spain, Revenue ($m), USD Constant, Historic, 2009-2016 41

Figure 24: Needle Free Injections Market, Spain, Revenue ($m), USD Constant, Forecast, 2016-2023 42

Figure 25: Needle Free Injections Market, Spain, Volume (Units), Historic, 2009-2016 43

Figure 26: Needle Free Injections Market, Spain, Volume (Units), Forecast, 2016-2023 44

Figure 27: Needle Free Injections Market, Spain, Company Share (%) 2016 47

Figure 28: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 49

Figure 29: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 50

Figure 30: Needle Free Injections Market, United Kingdom, Volume (Units), Historic, 2009-2016 51

Figure 31: Needle Free Injections Market, United Kingdom, Volume (Units), Forecast, 2016-2023 52

Figure 32: Needle Free Injections Market, United Kingdom, Company Share (%) 2016 55

1.1 List of Tables

Table 1: Needle Free Injections Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2009-2023 8

Table 2: Needle Free Injections Market, EU5, Revenue ($m), Historic, USD Constant, 2009-2016 9

Table 3: Needle Free Injections Market, EU5, Revenue ($m), Forecast, USD Constant, 2016-2023 10

Table 4: Needle Free Injections Market, EU5, Volume (Units), 2009-2023 12

Table 5: Needle Free Injections Market, EU5, Volume (Units), Historic, 2009-2016 13

Table 6: Needle Free Injections Market, EU5, Volume (Units), Forecast, 2016-2023 14

Table 7: Needle Free Injections Market, EU5, Company Share by Revenue ($m), USD Constant, 2016 16

Table 8: Needle Free Injections Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 17

Table 9: Needle Free Injections Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 18

Table 10: Needle Free Injections Market, France, Volume (Units), Historic, 2009-2016 19

Table 11: Needle Free Injections Market, France, Volume (Units), Forecast, 2016-2023 20

Table 12: Needle Free Injections Market, France, Average Price ($), Historic, 2009-2016 21

Table 13: Needle Free Injections Market, France, Average Price ($), Forecast, 2016-2023 21

Table 14: Needle Free Injections Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016 22

Table 15: Needle Free Injections Market, France, Company Share by Revenue ($m), USD Constant, 2016 24

Table 16: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 25

Table 17: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 26

Table 18: Needle Free Injections Market, Germany, Volume (Units), Historic, 2009-2016 27

Table 19: Needle Free Injections Market, Germany, Volume (Units), Forecast, 2016-2023 28

Table 20: Needle Free Injections Market, Germany, Average Price ($), Historic, 2009-2016 29

Table 21: Needle Free Injections Market, Germany, Average Price ($), Forecast, 2016-2023 29

Table 22: Needle Free Injections Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016 30

Table 23: Needle Free Injections Market, Germany, Company Share by Revenue ($m), USD Constant, 2016 32

Table 24: Needle Free Injections Market, Italy, Revenue ($m), USD Constant, Historic, 2009-2016 33

Table 25: Needle Free Injections Market, Italy, Revenue ($m), USD Constant, Forecast, 2016-2023 34

Table 26: Needle Free Injections Market, Italy, Volume (Units), Historic, 2009-2016 35

Table 27: Needle Free Injections Market, Italy, Volume (Units), Forecast, 2016-2023 36

Table 28: Needle Free Injections Market, Italy, Average Price ($), Historic, 2009-2016 37

Table 29: Needle Free Injections Market, Italy, Average Price ($), Forecast, 2016-2023 37

Table 30: Needle Free Injections Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2015-2016 38

Table 31: Needle Free Injections Market, Italy, Company Share by Revenue ($m), USD Constant, 2016 40

Table 32: Needle Free Injections Market, Spain, Revenue ($m), USD Constant, Historic, 2009-2016 41

Table 33: Needle Free Injections Market, Spain, Revenue ($m), USD Constant, Forecast, 2016-2023 42

Table 34: Needle Free Injections Market, Spain, Volume (Units), Historic, 2009-2016 43

Table 35: Needle Free Injections Market, Spain, Volume (Units), Forecast, 2016-2023 44

Table 36: Needle Free Injections Market, Spain, Average Price ($), Historic, 2009-2016 45

Table 37: Needle Free Injections Market, Spain, Average Price ($), Forecast, 2016-2023 45

Table 38: Needle Free Injections Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2015-2016 46

Table 39: Needle Free Injections Market, Spain, Company Share by Revenue ($m), USD Constant, 2016 48

Table 40: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 49

Table 41: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 50

Table 42: Needle Free Injections Market, United Kingdom, Volume (Units), Historic, 2009-2016 51

Table 43: Needle Free Injections Market, United Kingdom, Volume (Units), Forecast, 2016-2023 52

Table 44: Needle Free Injections Market, United Kingdom, Average Price ($), Historic, 2009-2016 53

Table 45: Needle Free Injections Market, United Kingdom, Average Price ($), Forecast, 2016-2023 53

Table 46: Needle Free Injections Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 54

Table 47: Needle Free Injections Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 56

Table 48: Needle Free Injections Market Pipeline Products 58

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

INJEX-Equidyne Systems

Bioject Medical Technologies Inc

Antares Pharma Inc

PharmaJet Inc

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd

select a license
Single User License
USD 5995 INR 433858
Site License
USD 11990 INR 867716
Corporate User License
USD 17985 INR 1301574

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com